Papers
2
Total Citations
32
H-Index
2
About
Jeong Woo Lee is a leading urologic surgeon and researcher whose work centers on advancing the surgical management of renal tumors, particularly through the comparative evaluation of open and robot-assisted partial nephrectomy (RAPN). His major contributions include demonstrating that RAPN is a safe and effective alternative to open surgery for renal tumors larger than 4 cm, a finding from his highly cited 2021 propensity score matching analysis (25 citations) that has helped guide clinical decision-making for complex cases. Lee has also pioneered the use of anatomical tumor features—specifically the PADUA score—to predict functional outcomes and warm ischemic time during RAPN, as shown in his 2014 study (7 citations). His work bridges surgical technique and patient-centered outcomes, providing evidence that robotic approaches can preserve renal function without compromising oncologic safety. With a growing citation impact, Lee is recognized for refining surgical indications and improving postoperative quality of life for kidney cancer patients. His research continues to shape best practices in minimally invasive urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2